Clinical Trials Directory

Trials / Completed

CompletedNCT04789005

Comparison of Phenylephrine and Norepinephrine for Spinal-induced Hypotension

Comparison of Intravenous Phenylephrine and Norepinephrine for Treatment of Spinal-induced Hypotension in Caesarian Deliveries

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Tribhuvan University Teaching Hospital, Institute Of Medicine. · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Hypotension after spinal anaesthesia for cesarean deliveries is frequently encountered. Phenylephrine an α-agonist is commonly used for the prevention and treatment of spinal-induced hypotension. Phenylephrine causes baroreceptor-mediated bradycardia leading to subsequent reduction in cardiac output. Preservation of heart rate and cardiac output is important in high-risk conditions such as placental insufficiency, fetal distress and maternal cardiac disease. Recently, norepinephrine has been found as effective as phenylephrine in treatment of spinal induced hypotension. When norepinephrine is used as a bolus, it is effective at maintaining blood pressure while also conferring a greater heart rate and cardiac output compared to phenylephrine.

Conditions

Interventions

TypeNameDescription
DRUGNorepinephrineNorepinephrine 8mcg was administered manually by the anaesthesiologist every time the SBP was 20% lower than baseline and the HR ≥60 bpm.
DRUGPhenylephrinePhenylephrine 100mcg was administered manually by the anaesthesiologist every time the SBP was 20% lower than baseline and the HR ≥60 bpm.

Timeline

Start date
2019-11-10
Primary completion
2020-05-05
Completion
2020-05-05
First posted
2021-03-09
Last updated
2021-03-09

Locations

1 site across 1 country: Nepal

Source: ClinicalTrials.gov record NCT04789005. Inclusion in this directory is not an endorsement.